← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2009Last known activity
Apr 21, 2022
Timeline
2000s
- Jan 1, 2009
Fondazione Italiana Diabete Onlus— Founded
Drugs by trial phase (58 distinct, 58 trials)
Phase 3 (29 own, 0 via acquisition)
Indications
Studied for
- Aggression
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hodgkin Disease
- Immunoblastic Lymphadenopathy
- Iron Overload
- Leukemia
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lymphatic Diseases
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Myelodysplastic Syndromes
- Preleukemia
- Syndrome
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT05249959Lead sponsorPhase 2Apr 21, 2022
- NCT05058404Lead sponsorPhase 3Nov 30, 2021
- NCT04915248Lead sponsorPhase 2Jun 1, 2021
- NCT04442412Lead sponsorPhase 3Sep 1, 2020
- NCT04433182Overall official - principal investigatorPhase 2Aug 1, 2020
- NCT04433182Lead sponsorPhase 2Aug 1, 2020
- NCT04251065Lead sponsorPhase 2Mar 1, 2020
- NCT03731234Lead sponsorPhase 2Jul 31, 2019
- NCT03890289Lead sponsorPhase 2Jun 30, 2019
- NCT03920657Lead sponsorPhase 2May 31, 2019
- NCT03891355Lead sponsorPhase 2Apr 30, 2019
- NCT03567876Lead sponsorPhase 2Jul 31, 2018
- NCT03552692Lead sponsorPhase 2Jun 15, 2018
- NCT03161054Lead sponsorPhase 2Jun 1, 2017
- NCT03159897Lead sponsorPhase 3Jun 1, 2017
Details
- Founded
- Milan, IT Jan 1, 2009
- Last known activity
- Apr 21, 2022